SCHEMBL1504794

SCHEMBL1504794

COc1cc2c(Nc3ccc4nc(NC(=O)Nc5ccccc5)sc4c3)ncnc2cc1OCCCN1CCCC1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 16/20 0.71
KDR P35968 15/20 0.71
BRAF P15056 2/20 0.60
AURKA O14965 7/20 0.60
AURKB Q96GD4 7/20 0.60
ROCK2 O75116 1/20 0.60
ALDH1A1 P00352 1/20 0.60
LCK P06239 1/20 0.60
FYN P06241 1/20 0.60
RET P07949 1/20 0.60
MET P08581 1/20 0.60
MAPT P10636 1/20 0.60
SRC P12931 1/20 0.60
PDGFRA P16234 1/20 0.60
LTK P29376 1/20 0.60
TTK P33981 1/20 0.60
MAP2K2 P36507 1/20 0.60
MAP2K1 Q02750 1/20 0.60
BTK Q06187 1/20 0.60
TYRO3 Q06418 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1504836 0.93 KDR (0.71) EGFRKDRBRAF
SCHEMBL1504807 0.92 EGFR (0.61) EGFRKDRBRAFAURKAAURKB
SCHEMBL1505014 0.91 EGFR (0.60) EGFRKDRAURKAAURKBPDGFRB
SCHEMBL3946804 0.90 EGFR (0.78) EGFRKDRAURKAAURKBPDGFRB
SCHEMBL1504863 0.89 KDR (0.58) EGFRKDRBRAFFLT4
SCHEMBL3947459 0.89 KDR (0.61) EGFRKDRBRAFAURKAAURKB
SCHEMBL3946268 0.89 AURKA (0.64) EGFRKDRBRAFAURKAAURKB
SCHEMBL1504960 0.89 EGFR (0.69) EGFRKDRBRAFAURKAAURKB
SCHEMBL3953826 0.89 AURKA (0.63) EGFRKDRBRAFAURKAAURKB
SCHEMBL2189126 0.89 EGFR (0.70) EGFRKDRAURKAAURKBPDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011033094-A1 SCHEDULE OF ADMINISTRATION OF BENZAZOLE DERIVATIVES IN THE TREATMENT OF LEUKEMIAS 4SC AG (DE) 2011-03-24 WO claimed